Researchers have identified an enzyme in the Staphylococcus aureus bacterium that modifies the structure of the bacterium’s cell wall and may increase its resistance to the antibiotic vancomycin. The discovery offers a new perspective on how bacteria adapt to antibiotic resistance and may help in the future to develop future strategies to combat antimicrobial resistance.
Antimicrobial resistance represents one of the major challenges facing modern medicine. Especially worrying are bacterias that develop resistance to antibiotics that are the last available treatment options.
Researchers from the Universities of Jyväskylä and Helsinki (Finland) have discovered a previously unknown mechanism by which Staphylococcus aureus, an important human pathogen, remodels its protective cell wall and responds to the antibiotic vancomycin.
A study led by Professor Perttu Permi from the University of Jyväskylä has been published in the prestigious scientific journal Nature Communications.
A new perspective on bacterial cell-wall biology
Staphylococcus aureus is particularly notorious for its ability to develop resistance to multiple antibiotics, including vancomycin, which is commonly used to treat serious infections caused by resistant staphylococci.
The study examined an enzyme called LytU, which is involved in the modification of the bacterial cell wall. The bacterial cell wall is a complex protective structure. The cell wall protects them from external stresses, maintains the cell shape and is also a target for many antibiotics. The main component of the cell wall is peptidoglycan.
The researchers discovered that LytU performs an unexpected enzymatic function.
- To our surprise, LytU did not behave like other known proteins belonging to the same enzyme family. Instead of cutting the usual bonds in peptidoglycan, it broke a specific bridge bond in the cell wall structure that plays a key role in cell wall cross-linking, explains Professor Perttu Permi of the University of Jyväskylä.
An unexpected connection to vancomycin resistance
Importantly, the study reveals that LytU activity must be tightly regulated. While increased LytU expression can enhance vancomycin resistance, excessive enzyme activity disrupts normal cell-wall construction.
In the experiments, the bacteria that produced more LytU enzyme were about 30 times more resistant to vancomycin than the control bacteria.
- What makes this discovery particularly exciting is that we have identified an enzyme that connects two seemingly opposing processes: bacterial cell-wall remodeling and antibiotic resistance. It gives us a new perspective on how Staphylococcus aureus adapts its cell wall in response to antibiotic stress, says Permi.
Although further studies are needed to establish the contribution of LytU to antibiotic resistance in clinical isolates and adapted resistant strains.
- This discovery provides a new molecular perspective on the relationship between cell-wall remodeling and antimicrobial resistance, explains Permi.
New understanding of the factors behind antibiotic resistance
The research provides new insights about how Staphylococcus aureus builds and modifies its cell wall and how the bacterium can survive under antibiotic pressure. The results show that minor modifications to the cell wall structure can affect the activity of antibiotics.
This discovery offers researchers a new perspective on bacterial defense mechanisms and may help in the future develop new strategies to fight antibiotic resistance.